In recent years, ketamine has emerged as a groundbreaking treatment option for various mental health conditions, particularly depression, anxiety, PTSD, and chronic pain disorders.
Enveric Biosciences (NASDAQ: ENVB) is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction ...